Combination of olaparib and savolitinib overcomes olaparib-resistance in epithelial ovarian cancer models

Minje Kim(University of Illinois Urbana-Champaign), Yong‐Man Kim(Asan Medical Center)
Research Square
February 14, 2023
Cited by 0


Related Papers